novo nordisk cuts glp-1 drug prices for cash-paying customers. bets on lower to counter Lilly's Zepbound surge Novo Nordisk Cuts GLP-1 Prices

A new review explores how GLP-1 receptor agonists may blunt alcohol and drug reward signals, opening a promising but still unproven path toward repurposed treatments for addiction

Other potential risks include gallbladder problems (including gallstones), kidney problems (particularly in patients with existing kidney disease who become dehydrated), and hypoglycemia when combined with other diabetes medications

Exogenous Glucose-Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in Type 2 Diabetes

The medication has a 7-day half-life, meaning its effects are continuous and cumulative

Our comprehensive approach to weight loss comes with support from medical providers who understand the nuance of weight gain and weight loss

Nonetheless, a primary role of GLP-1 in post-surgical improvement of metabolism is controversial